Frontiers | Personalized in vitro Extracellular Matrix Models of Collagen VI-Related Muscular Dystrophies
Untitled
Cloé LELEU - Directrice générale - CL CONSULTING | LinkedIn
Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort | PLOS ONE
IT'S LIKE MAGIC
Best Lawyers Fall Business Edition 2020 by Best Lawyers - Issuu
Guide to the archives of intergovernmental organizations
Multiple myeloma: Optimal management and long-term disease control - Cancer Therapy Advisor
PDF) Fish and invertebrate life histories and important fisheries of the Pangani River Basin, Tanzania
Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review - McCaughan - 2022 - British Journal of Haematology - Wiley Online Library
SciELO - Brasil - Posicionamento sobre Diagnóstico e Tratamento da Amiloidose Cardíaca – 2021 Posicionamento sobre Diagnóstico e Tratamento da Amiloidose Cardíaca – 2021
PDF) Assessing libraries and library users and use: proceedings of the 13th international conference Libraries in the Digital Age (LIDA), Zadar, 16-20 June 2014 | Boris Bosančić - Academia.edu
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients | British Journal of Cancer
PDF) Veterinary Science | Moustafa M Zeitoun - Academia.edu
Cloé LELEU - Directrice générale - CL CONSULTING | LinkedIn
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial - The Lancet Haematology
Cloé LELEU - Directrice générale - CL CONSULTING | LinkedIn
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life | Blood Cancer Journal
Molecules | Free Full-Text | Antioxidant Properties and Aldehyde Reactivity of PD-L1 Targeted Aryl-Pyrazolone Anticancer Agents
Journal of Psychophysiology by Hogrefe - Issuu
Bumetanide for autism: more eye contact, less amygdala activation | Scientific Reports
Robert Z. Orlowski | MD Anderson Cancer Center
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review - McCaughan - 2022 - British Journal of Haematology - Wiley Online Library
National Task Force on Medical Staffing
Cloé LELEU - Directrice générale - CL CONSULTING | LinkedIn
Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment - Zhang - Advanced Science - Wiley Online Library
